First tranche delivered, larger tranches en route: the same engine that just produced has visibly more already scheduled
The model's full reasoning — Q2 2018 call → NOWe need answer YES/NO. Need analyze transcript. Need identify ONE identifiable engine of new business with first tranche landed and larger tranches in motion same engine, remainder larger, management affirms. Need be strict. Let's parse transcript. Management discusses many products. Need find specific engine where first tranche actually delivered in Q2 and larger tranches already committed/scheduled/ramping, remainder larger. Examples: TREMFYA launched, $126 million, 15k patients, 5% share. Is that first tranche landed? Yes, sales recognized. Larger tranches in motion? Management says strong demand, new launches, but not necessarily committed volumes; it's ongoing market adoption, not secured tranches. Probably no. ATTUNE revision launch? They say improved performance, new product launches, but not specific tranches. Baby relaunch: newly formulated Johnson's Baby products started shipping in July (after quarter) so not in Q2. Not landed in reported period. Medical Devices 15-20 launches, 60% way there. But not specific engine with first tranche and larger committed. Actelion acquisition? Not new engine? Already acquired, ongoing. Maybe "ERLEADA" launched earlier in 2018? Not in Q2? They mention launched earlier this year. But no tranches. Need find management describes a specific contract/program/product with first delivery and continuation. Maybe "Concise Surgical Automated System" acquisition completed after quarter, not landed. Maybe "LifeScan divestiture" not engine. Maybe "UPTRAVI/OPSUMIT" growth, but not tranches. Maybe "ESKETAMINE" filing soon, not landed. Maybe "TREMFYA" has 15k patients, 5% share, but continuation is expected demand, not secured. Maybe "newly formulated Johnson's Baby products started shipping in July" - first tranche? It's after quarter, but management says "started to ship" in July, not in reported period. Also larger tranches? They say revitalizing Baby business, planned launches, but not concrete. Maybe "Medical Devices new product launches" with 60% launched, 40% ahead. But not same engine? It's a portfolio of launches, not one engine. Management doesn't say remainder larger than delivered. Maybe "Pharmaceutical launches up to ten new therapeutics by 2021" - not landed. Maybe "Actelion pulmonary hypertension assets" - Q2 strongest quarter, OPSUMIT/UPTRAVI growth. But no tranches.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| ATAT | Atour Lifestyle Holdings Limited | Q1 2024 | 2024-05-23 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| E | Eni S.p.A. | Q1 2024 | 2024-04-24 | B+ |
| FRPH | FRP Holdings, Inc. | Q4 2023 | 2024-03-07 | C+ |
| ZLAB | Zai Lab Limited | Q4 2023 | 2024-02-28 | C |
| VMI | Valmont Industries, Inc. | Q4 2023 | 2024-02-22 | C |
| TBLA | Taboola.com Ltd. | Q3 2023 | 2023-11-08 | B+ |
| JLL | Jones Lang LaSalle Incorporated | Q3 2023 | 2023-11-02 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| CLNE | Clean Energy Fuels Corp. | Q2 2023 | 2023-08-09 | C+ |
| LUCD | Lucid Diagnostics Inc. | Q1 2023 | 2023-05-16 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| ARE | Alexandria Real Estate Equities, Inc. | Q4 2022 | 2023-01-31 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| CDMO | Avid Bioservices, Inc. | Q3 2022 | 2022-03-08 | B+ |
| DG | Dollar General Corporation | Q2 2021 | 2021-08-26 | A |
| DOV | Dover Corporation | Q2 2021 | 2021-07-20 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| FEIM | Frequency Electronics, Inc. | Q1 2019 | 2018-09-13 | B+ |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MGA | Magna International Inc. | Q1 2018 | 2018-05-10 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| HR | Healthcare Realty Trust Incorporated | Q1 2017 | 2017-05-08 | A |
| BDN | Brandywine Realty Trust | Q1 2017 | 2017-04-21 | C+ |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| MTRX | Matrix Service Company | Q3 2016 | 2016-05-05 | D |
| CLF | Cleveland-Cliffs Inc. | Q1 2016 | 2016-04-29 | F |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
CDMO · Q3 2022 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: NO The transcript describes the first phase of the Myford expansion as now operational and scheduling client projects, with management noting they are already utilizing the new space and that an extra $5 million is arguably in backlog attributable to it.
LINC · Q1 2024 → YESThe question is about whether management describes ONE identifiable engine of new business that meets two criteria: YES The transcript identifies the new-campus expansion strategy as the engine. East Point opened in Q1 with 29 starts and $90k revenue (first tranche, concrete and delivered).
LTRX · Q3 2024 → YESThe question is about whether management describes one identifiable engine of new business that meets two criteria: a first tranche has actually landed in the just-reported period, and larger tranches...